Poised for Breakout with Strong Q4 Results and Strategic Merger
✅ Sun Pharmaceutical Industries is forming a symmetrical triangle pattern with support around INR 1,450 and resistance at INR 1,560. A breakout above 1,560 could signal a strong upward movement towards INR 1,650 and beyond.
✅ Sun Pharma reported a projected net profit increase of 18.4% for Q4 FY24, reaching INR 2,347 crore. The company has also recently secured shareholder approval for its merger with Taro Pharmaceutical Industries, expected to close soon, which will enhance its global market presence and capabilities.
Join our community in telegram for real time updates --- telegram.me/marketiik
Telegram- telegram.me/marketiik
A simple trader, distancing from the fake crowd. Simplifying complexity, I prioritize genuine insights over trends.
Telegram- telegram.me/marketiik
A simple trader, distancing from the fake crowd. Simplifying complexity, I prioritize genuine insights over trends.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Join our community in telegram for real time updates --- telegram.me/marketiik
Telegram- telegram.me/marketiik
A simple trader, distancing from the fake crowd. Simplifying complexity, I prioritize genuine insights over trends.
Telegram- telegram.me/marketiik
A simple trader, distancing from the fake crowd. Simplifying complexity, I prioritize genuine insights over trends.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.